| Literature DB >> 32709048 |
Hanan I Althagbi1,2, Walied M Alarif3, Khalid O Al-Footy2, Ahmed Abdel-Lateff4,5.
Abstract
TheEntities:
Keywords: biological activity; macrocyclic alkaloids; marine natural products; potential drugs
Mesh:
Substances:
Year: 2020 PMID: 32709048 PMCID: PMC7404069 DOI: 10.3390/md18070368
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Percentage of marine-derived macrocyclic alkaloids’ subclasses.
List of marine-derived macrocyclic alkaloids.
| Compound No. | Subclasses | Name of Compounds | Marine Organism | Biological Activities |
|---|---|---|---|---|
|
| Pyrroles | Densanins A and B |
| Anti-inflammatory |
|
| Quinolines | Njaoamines A–F | Cytotoxic and | |
|
| Njaoamines G–H | |||
|
| Njaoamine I | |||
|
| Bis-Quinolizidines | Petrosin |
| |
|
| Petrosins A and B | |||
|
| Aragupetrosine A | |||
|
| Xestosin A |
| ||
|
| Xestospongin A (Araguspongine D) | |||
|
| Xestospongin B | |||
|
| Xestospongin C (Araguspongine E) | |||
|
| Xestospongin D (Araguspongine A) | |||
|
| Xestospongins E–J | |||
|
| (+)-7 | |||
|
| Demethylxestospongin B | |||
|
| 3β,3ʹβ-Dimethylxestospongin C | |||
|
| 9′- | |||
|
| Araguspongine B | Antimicrobial and Cytotoxic | ||
|
| Araguspongine C |
| ||
|
| Araguspongines F–H and J | |||
|
| 3a-Araguspongin C |
| ||
|
| Araguspongines K and L |
| ||
|
| Araguspongine M | |||
|
| Araguspongines N–P |
| ||
|
| ||||
|
| 3-Alkyl | Saraines 1–3 |
| Cytotoxic |
|
| Isosaraines 1–3 | Antimicrobial | ||
|
| Saraines A-C | |||
|
| Madangamines A–E |
| Cytotoxic | |
|
| Madangamine F |
| ||
|
| (10 |
| Antimicrobial | |
|
| (10 |
| ||
|
| Papuamine | |||
|
| Haliclonadiamine | |||
|
| Ingamines A and B |
| Antimalarial | |
|
| Ingenamine | |||
|
| Ingenamines B–F | |||
|
| Ingenamine G | |||
|
| Dihydroingenamine D |
| ||
|
| 22( | |||
|
| Xestocyclamine | protein kinase C inhibitor | ||
|
| Halicyclamines A-B | Cytotoxic | ||
|
| Haliclonacyclamines A–B | |||
|
| 22-Hydroxyhaliclonacyclamine B | |||
|
| 2- | |||
|
| Tetradehydrohaliclonacyclamine A mono- | |||
|
| Tetradehydrohaliclonacyclamine A | |||
|
| Haliclonacyclamine C | |||
|
| Haliclonacyclamine D | |||
|
| Haliclonacyclamine E |
| Antimalarial, | |
|
| Haliclonacyclamine F |
| ||
|
| Halichondramine | |||
|
| Neopetrosiamine A |
| ||
|
| Tetradehydrohalicyclamine B |
| ||
|
| Arenosclerins A–C |
| Cytotoxic, | |
|
| Arenosclerins D and E |
| ||
|
| Manzamines | Manzamine A (Keramamine A) | ||
|
| 8-Hydroxymanzamine A (Manzamine G) | |||
|
| 3,4-Dihydromanzamine A | |||
|
| 6-Hydroxymanzamine A (Manzamine Y) | |||
|
| 1,2,3,4-Tetrahydro-8-hydroxymanza-mine A | |||
|
| 1,2,3,4-Tetrahydro-2- | |||
|
| Manzamine D (1,2,3,4-Tetrahydromanzamine A) | |||
|
| 3,4-Dihydro-6-hydroxymanzamine A | |||
|
| Manzamine M | |||
|
| Unidentified Paluan sponge | |||
|
| ||||
|
| 12,34-Oxamanzamine A | Sponge 011ND 35 | ||
|
| Unidentified Indo-Pacific sponge | |||
|
| 12,28-Oxamanzamine A | |||
|
| 12,28-Oxa-8-hydroxymanzamine A | |||
|
| Manzamine A |
| ||
|
| 3,4-Dihydromanzamine A | |||
|
| Acanthomanzamines A and B | |||
|
| Pre- |
| ||
|
| Zamamidine C | |||
|
| Zamamidine D | |||
|
| Nakadomarin A | |||
|
| Ircinol A | |||
|
| Ircinal A | |||
|
| Ircinal E | |||
|
| 12,28-Oxaircinal A | |||
|
| Manzamine E | |||
|
| Manzamine F (Keramamine B) | |||
|
| ||||
|
| Sponge 011ND 35 | |||
|
| 12,34-Oxamanzamine E | |||
|
| 6-Hydroxymanzamine E | |||
|
| 12,28-Oxamanzamine E | |||
|
| 12,34-Oxa-6-hydroxymanzamine E | |||
|
| 31-Keto-12,34-oxa-32,33-dihydroircinal A | |||
|
| Manzamine B | |||
|
| Manzamines H, J | |||
|
| Manzamine J |
| ||
|
| 8-Hydroxymanzamine B | |||
|
| Manzamine L | |||
|
| Manzamine B | |||
|
| 3,4-Dihydromanzamine B | |||
|
| 11-Hydroxymanzamine J | |||
|
| Ma’eganedin A | |||
|
| 8-Hydroxymanzamine J |
| ||
|
| 3,4-Dihydromanzamine J | |||
|
| Acanthomanzamines D and E | |||
|
| Zamamidines A and B | |||
|
| Ircinal B | |||
|
| Ircinol B | |||
|
| Manzamine C | Cytotoxic | ||
|
| Keramamine C | |||
|
| Acanthomanzamine C | |||
|
| Kepulauamine A | |||
|
| Acantholactam | |||
|
| Acantholactone | |||
|
| 32,33-Dihydro-31-hydroxymanzamine A | Indonesian sponge | ||
|
| 32,33-Dihydro-6-hydroxymanzamine A-35-one | |||
|
| 32,33-Dihydro-6,31-dihydroxymanzamine A | |||
|
| Manzamine X |
| ||
|
| 6-Deoxymanzamine X |
| ||
|
| Manadomanzamines A and B | |||
|
| Keramaphidin B | |||
|
| Kauluamine | |||
|
| 3-Alkyl | Cyclostellettamines A–F |
| Antimicrobial and |
|
| Cyclostellettamines G–I, K, and L | |||
|
| Dehydrocyclostellettamines D, E | |||
|
| 8,8‘-Dienecyclostellettamine |
| ||
|
| Cyclostellettamines N, R, O, Q | |||
|
| Cyclostellettamines | |||
|
| Cyclostellettamine P |
| ||
|
| Njaoaminiums A–C | Cytotoxic | ||
|
| Motuporamines | Motuporamines A–I |
| Anti-invasion |
Figure 2Structures 1 and 2.
Figure 3Structures of 3–11.
Figure 4Structures of 12–16.
Figure 5Structures of 17–44.
Figure 6Structures of 45–53.
Figure 7Structures of 54–59.
Figure 8Structures of 60–64.
Figure 9Structures of 65–76.
Figure 10Structures of 77–96.
Figure 11Structures of 97–113.
Figure 12Structures of 114–133.
Figure 13Structures of 134–151.
Figure 14Structures of 152–166.
Figure 15Structures of 167–196.
Figure 16Structures of 197–205.
Figure 17Plausible biosynthetic pathway of densanin A.
Figure 18Biosynthetic considerations of the macrocyclic alkaloids originated from 3-alkylpiperidine.